The DOI matches its Crossref record; 375 of the 379 references it cites were found in a registry or an index.
Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders
Abstract
ABC (ATP-binding cassette) transporters represent one of the largest and most diverse superfamily of proteins in living species, playing an important role in many biological processes such as cell homeostasis, cell signaling, drug metabolism and nutrient uptake. Moreover, using the energy generated from ATP hydrolysis, they mediate the efflux of endogenous and exogenous substrates from inside the cells, thereby reducing their intracellular accumulation. At present, 48 ABC transporters have been identified in humans, which were classified into 7 different subfamilies (A to G) according to their phylogenetic analysis. Nevertheless, the most studied members with importance in drug therapeutic efficacy and toxicity include P-glycoprotein (P-gp), a member of the ABCB subfamily, the multidrug-associated proteins (MPRs), members of the ABCC subfamily, and breast cancer resistance protein (BCRP), a member of the ABCG subfamily. They exhibit ubiquitous expression throughout the human body, with a special relevance in barrier tissues like the blood-brain barrier (BBB). At this level, they play a physiological function in tissue protection by reducing or limiting the brain accumulation of neurotoxins. Furthermore, dysfunction of ABC transporters, at expression and/or activity level, has been associated with many neurological diseases, including epilepsy, multiple sclerosis, Alzheimer's disease, and amyotrophic lateral sclerosis. Additionally, these transporters are strikingly associated with the pharmacoresistance to central nervous system (CNS) acting drugs, because they contribute to the decrease in drug bioavailability. This article reviews the signaling pathways that regulate the expression and activity of P-gp, BCRP and MRPs subfamilies of transporters, with particular attention at the BBB level, and their mis-regulation in neurological disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the AD context, from the 48 ABC transporters identified, the P-glycoprotein (P-gp) is recognized as one of the Aβ efflux pumps [19].”
From Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease (2026) · cites this paper as [19]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Kwan, P., Arzimanoglou, A. A., Berg, A. T., Brodie, M. J., Hauser, W. A., Mathern, G. W., Moshé, S. L., Perucca, E., Wiebe, S., & French, J. A. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02397.x · Cited by 4,918
Compston, A., & Coles, A. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,699
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. W. T. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,317
Defining the clinical course of multiple sclerosis: The 2013 revisions
Lublin, F. D., Reingold, S. C., Cohen, J. A., Cutter, G. R., Sørensen, P. S., Thompson, A. J., Wolinsky, J. S., Balcer, L. J., Banwell, B., Barkhof, F., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000560 · Cited by 3,177
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M., Pastan, I., & Willingham, M. (1987) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.84.21.7735 · Cited by 2,823
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Brown, R. H., & Al‐Chalabi, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1603471 · Cited by 2,580
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,372
Donnan, G. A., Fisher, M., Macleod, M. R., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,288
Hardiman, O. M., Al‐Chalabi, A., Chiò, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 2,262
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.56 · Cited by 1,853
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,427
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,426
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,407
Samii, A., Nutt, J. G., & Ransom, B. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16305-8 · Cited by 1,361
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308
The human ATP-binding cassette (ABC) transporter superfamily
Dean, M., Hamon, Y., & Chimini, G. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31588-1 · Cited by 1,302
A Cellular Perspective on Brain Energy Metabolism and Functional Imaging
Magistretti, P. J., & Allaman, I. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.035 · Cited by 1,285
Tight junctions of the blood-brain barrier: development, composition and regulation.
Wolburg, H., & Lippoldt, A. (2002) · PubMed · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,236
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,236
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer‐Lindenberg, A., Weinberger, D. R., Cannon, T. D., O’Donovan, M. C., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,163
Hyde, S. C., Emsley, P., Hartshorn, M. J., Mimmack, M. M., Gileadi, U., Pearce, S. R., Gallagher, M. P., Gill, D. R., Hubbard, R. E., & Higgins, C. F. (1990) · Nature · doi:10.1038/346362a0 · Cited by 1,145
Alzheimer's disease: strategies for disease modification
Citron, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2896 · Cited by 1,075
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Doyle, L. A., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,056
The Diagnosis of Mental Disorders: The Problem of Reification
Hyman, S. E. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091532 · Cited by 1,052
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & WITT, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 984
ABC Multidrug Transporters: Structure, Function and Role in Chemoresistance
Sharom, F. J. (2007) · Pharmacogenomics · doi:10.2217/14622416.9.1.105 · Cited by 973
P-Glycoprotein, a gatekeeper in the blood–brain barrier
Schinkel, A. H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00085-4 · Cited by 963
Current Strategies for Brain Drug Delivery
Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1728 · Cited by 920
Blood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2004) · NeuroRx · doi:10.1602/neurorx.2.1.86 · Cited by 873
Levin, V. A. (1980) · Journal of Medicinal Chemistry · doi:10.1021/jm00180a022 · Cited by 817
Bleau, A., Hambardzumyan, D., Ozawa, T., Fomchenko, E. I., Huse, J. T., Brennan, C., & Holland, E. C. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.01.007 · Cited by 803
Human ATP-binding cassette (ABC) transporter family
Vasiliou, V., Vasiliou, K., & Nebert, D. W. (2008) · Human Genomics · doi:10.1186/1479-7364-3-3-281 · Cited by 779
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Blood–brain barrier dysfunction in parkinsonian midbrain in vivo
Kortekaas, R., Leenders, K. L., van Oostrom, J. C. H., Vaalburg, W., Bart, J., Willemsen, A. T. M., & Hendrikse, N. H. (2005) · Annals of Neurology · doi:10.1002/ana.20369 · Cited by 733
Chang, B. S., & Lowenstein, D. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022308 · Cited by 730
The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses
Deeken, J. F., & Löscher, W. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2854 · Cited by 724
Deeks, S. G., Overbaugh, J. M., Phillips, A. N., & Buchbinder, S. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 718
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 708
Diagnosis of multiple sclerosis: progress and challenges
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump.
Zaman, G. J., Flens, M. J., van Leusden, M. R., de Haas, M., MÜLDER, H. S., Lankelma, J., Pinedo, H. M., Scheper, R. J., Baas, F., & Broxterman, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8822 · Cited by 679
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 672
Siddiqui, A. T. S., Kerb, R., Weale, M. E., Brinkmann, U., Smith, A. C., Goldstein, D. B., Wood, N. W., & Sisodiya, S. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021986 · Cited by 668
Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638
Emerging Concepts in the Immunopathogenesis of AIDS
Douek, D. C., Roederer, M., & Koup, R. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.60.041807.123549 · Cited by 633
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 631
Plasma β-amyloid in Alzheimer's disease and vascular disease
Janelidze, S., Stomrud, E., Palmqvist, S., Zetterberg, H., van Westen, D., Jeromin, A., Song, L., Hanlon, D., Tan Hehir, C. A., Baker, D., et al. (2016) · Scientific Reports · doi:10.1038/srep26801 · Cited by 626
Translocation and potential neurological effects of fine and ultrafine particles a critical update
Peters, A., Veronesi, B., Calderón‐Garcidueñas, L., Gehr, P., Chen, L., Geiser, M., Reed, W. R., Rothen‐Rutishauser, B., Schürch, S., & Schulz, H. (2006) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-3-13 · Cited by 624
The MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 615
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 594
Neuropathologic changes in Alzheimer's disease.
Wenk, G. L. (2003) · PubMed · Cited by 554
ABC Transporters and the Blood-Brain Barrier
Begley, D. J. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384844 · Cited by 548
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
The P-glycoprotein multidrug transporter
Sharom, F. J. (2011) · Essays in Biochemistry · doi:10.1042/bse0500161 · Cited by 528
In silico prediction of blood–brain barrier permeation
Clark, D. E. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02827-7 · Cited by 501
Epidemiology of Ischemic and Hemorrhagic Stroke: Incidence, Prevalence, Mortality, and Risk Factors
Grysiewicz, R. A., Thomas, K., & Pandey, D. K. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.07.003 · Cited by 491
Goldenberg, M. M. (1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers
Tang, F., Hartz, A. M. S., & Bauer, B. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00301 · Cited by 483
Sisodiya, S. M., Lin, W.-R., Harding, B. N., Squier, M. V., & Thom, M. (2002) · Brain · doi:10.1093/brain/awf002 · Cited by 477
Structural and functional aspects of the blood-brain barrier
Begley, D. J., & Brightman, M. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8049-7_2 · Cited by 474
Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation
Abbott, N. J. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1374-y · Cited by 471
Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein
Selkoe, D. J. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3111 · Cited by 466
Farace, C., Melguizo, C., Asara, Y., Álvarez, P., Prados, J. C., Tolu, P., Delogu, G., Aránega, A., & Madeddu, R. (2011) · Cited by 458
Saturnino, C., Popolo, A., Ramunno, A., Adesso, S., Pecoraro, M., Plutino, M. R., Rizzato, S., Albinati, A., Marzocco, S., Sala, M., et al. (2017) · Molecules · doi:10.3390/molecules22040616 · Cited by 451
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of ManagementPreprint
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 449
Dombrowski, S. M., Desai, S. Y., Marroni, M., Cucullo, L., Goodrich, K., Bingaman, W. E., Mayberg, M. R., Križanac-Bengez, L., & Janigro, D. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.12301.x · Cited by 427
Role of Multidrug Transporters in Pharmacoresistance to Antiepileptic Drugs
Löscher, W., & Potschka, H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.7 · Cited by 410
Baltazar, M. T., Dinis‐Oliveira, R. J., Bastos, M. D. L., Tsatsakis, A. M., Duarte, J. A., & Carvalho, F. D. (2014) · Toxicology Letters · doi:10.1016/j.toxlet.2014.01.039 · Cited by 410
Miller, D. S., Bauer, B., & Hartz, A. M. S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07109 · Cited by 407
Nies, A. T., Jedlitschky, G., König, J., Herold‐Mende, C. C., Steiner, H. H., Schmitt, H.-P., & KEPPLER, D. O. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 399
RUSSEL, F., KOENDERINK, J., & MASEREEUW, R. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.01.006 · Cited by 383
Drugs as P-glycoprotein substrates, inhibitors, and inducers
Kim, R. B. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001389 · Cited by 382
β‐Amyloid efflux mediated by p‐glycoprotein
Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 379
Role of the Blood–Brain Barrier in Multiple Sclerosis
Ortiz, G. G., Pacheco-Moisés, F. P., Macías-Islas, M. Á., Flores-Alvarado, L. J., Mireles-Ramírez, M. A., González-Renovato, E. D., Hernández-Navarro, V. E., Sánchez-López, A. L., & Alatorre-Jiménez, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.013 · Cited by 373
Neuroprotective role of the innate immune system by microglia
Glezer, I., Simard, A. R., & Rivest, S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.055 · Cited by 371
Reid, G., Wielinga, P. R., Zelcer, N., de Haas, M., van Deemter, L., Wijnholds, J., Balzarini, J. M., & Borst, P. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1094 · Cited by 368
Regulation of P-glycoprotein and other ABC drug transporters at the blood–brain barrier
Miller, D. S. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.003 · Cited by 359
Vogelgesang, S., Cascorbi, I., Schroeder, E., Pahnke, J., Kroemer, H. K., Siegmund, W., Kunert‐Keil, C., Walker, L. C., & Warzok, R. (2002) · Pharmacogenetics · doi:10.1097/00008571-200210000-00005 · Cited by 357
Overview: ABC Transporters and Human Disease
Gottesman, M. M., & Ambudkar, S. V. (2001) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1012866803188 · Cited by 355
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
Self-citationMolecular insights on the cerebral innate immune system
Rivest, S. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00055-7 · Cited by 338
Hartz, A. M. S., Miller, D. S., & Bauer, B. (2010) · Molecular Pharmacology · doi:10.1124/mol.109.061754 · Cited by 329
ABC transporter research: going strong 40 years on
Theodoulou, F. L., & Kerr, I. D. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150139 · Cited by 328
Parkinson's disease and pesticides: a toxicological perspective
Hatcher, J. M., Pennell, K. D., & MILLER, G. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.03.007 · Cited by 319
Zhou, S.-F., Wang, L.-L., Di, Y., Xue, C., Duan, W., Li, C., & Li, Y. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132870 · Cited by 318
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
Dallas, S., Miller, D. S., & Bendayan, R. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.3 · Cited by 312
The blood–brain barrier in psychosis
Pollak, T. A., Drndarski, S., Stone, J. M., David, A. S., McGuire, P. K., & Abbott, N. J. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30293-6 · Cited by 311
Current and future treatments in Alzheimer’s disease
Atri, A. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1678581 · Cited by 309
Drug efflux transporters in the CNS
Sun, H., Dai, H. I., Shaik, N. M., & Elmquist, W. F. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00172-2 · Cited by 305
Zou, K., Gong, J.-S., Yanagisawa, K., & Michikawa, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04833.2002 · Cited by 305
McFaline-Figueroa, J. R., & Lee, E. Q. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.12.039 · Cited by 299
Multidrug resistance-associated proteins 3, 4, and 5
Borst, P., de Wolf, C., & van de Wetering, K. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0054-9 · Cited by 296
Genetics of Amyotrophic Lateral SclerosisPreprint
Ghasemi, M., & Brown, R. H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024125 · Cited by 292
Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier
Mikitsh, J. L., & Chacko, A. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13384 · Cited by 284
ABCG2 ? a transporter for all seasons
Sarkadi, B., Özvegy‐Laczka, C., Német, K., & Váradi, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.123 · Cited by 282
Structure and function of efflux pumps that confer resistance to drugs
Borges-Walmsley, M. I., McKeegan, K. S., & Walmsley, A. R. (2003) · Biochemical Journal · doi:10.1042/bj20020957 · Cited by 278
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Agarwal, S., Hartz, A. M. S., Elmquist, W. F., & Bauer, B. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797440186 · Cited by 275
Bauer, B., Hartz, A. M. S., & Miller, D. S. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029512 · Cited by 275
Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2
Xu, J., Liu, Y., Yang, Y., Bates, S. E., & Zhang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310785200 · Cited by 275
Bauer, B., Hartz, A. M. S., Pekcec, A., Toellner, K., Miller, D. S., & Potschka, H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041210 · Cited by 270
Hartz, A. M. S., Bauer, B., Block, M. L., Hong, J., & Miller, D. S. (2008) · The FASEB Journal · doi:10.1096/fj.08-106997 · Cited by 269
Tissue Distribution and Induction of Human Multidrug Resistant Protein 3
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M. L., Pijnenborg, A. C. L. M., Bosman, D. K., Elferink, R. P. J. O., van der Valk, P., Borst, P., & Scheper, R. J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780411 · Cited by 266
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
Montanari, F., & Ecker, G. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.001 · Cited by 265
Bartels, A. L., Willemsen, A., Kortekaas, R., de Jong, B. M., de Vries, R., de Klerk, O., van Oostrom, J. C. H., Portman, A. T., & Leenders, K. L. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0030-y · Cited by 261
Beaulieu, É., Demeule, M., Ghitescu, L. D., & Béliveau, R. (1997) · Biochemical Journal · doi:10.1042/bj3260539 · Cited by 253
The “rights” of precision drug development for Alzheimer’s disease
Cummings, J. L., Feldman, H., & Scheltens, P. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0529-5 · Cited by 252
Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders
Qosa, H., Miller, D. S., Pasinelli, P., & Trotti, D. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.005 · Cited by 249
Gerk, P. M., & Vore, M. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035014 · Cited by 249
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 243
Impaired blood–brain/spinal cord barrier in ALS patients
Garbuzova-Davis, S. N., Hernandez‐Ontiveros, D. G., Rodrigues, M. C. O., Haller, E. M., Frisina-Deyo, A. J., Mirtyl, S., Sallot, S. A., Saporta, S., Borlongan, C. V., & Sanberg, P. R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.056 · Cited by 242
Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS
Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.044 · Cited by 239
Potschka, H., Fedrowitz, M., & Löscher, W. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049858 · Cited by 234
Kuhnke, D., Jedlitschky, G., Grube, M., Krohn, M., Jucker, M., Mosyagin, I., Cascorbi, I., Walker, L. C., Kroemer, H. K., Warzok, R., et al. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00075.x · Cited by 232
The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
Kis, O., Robillard, K. R., Chan, G. N. Y., & Bendayan, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.10.001 · Cited by 226
Brandt, C., Bethmann, K., Gastens, A. M., & Löscher, W. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.014 · Cited by 222
Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood–brain barrier
Demeule, M., Régina, A., Jodoin, J., Laplante, A., Dagenais, C., Berthelet, F., Moghrabi, A., & Béliveau, R. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00201-x · Cited by 220
Evolving basic, pathological and clinical concepts in PD
Kalia, L. V., & Lang, A. E. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.249 · Cited by 216
Xiong, H., Callaghan, D., Jones, A., Bai, J., Rasquinha, I., Smith, C., Pei, K., Walker, D. G., Lue, L., Stanimirovic, D. B., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-08.2009 · Cited by 214
Uddin, M. S., Kabir, M. T., Al Mamun, A., Abdel-Daim, M. M., Barreto, G. E., & Ashraf, G. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1237-z · Cited by 212
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy
Tan, N. C., Heron, S. E., Scheffer, I. E., Pelekanos, J. T., McMahon, J. M., Vears, D. F., Mulley, J. C., & Berkovic, S. F. (2004) · Neurology · doi:10.1212/01.wnl.0000137051.33486.c7 · Cited by 211
A primer on the mechanics of P-glycoprotein the multidrug transporter
Hennessy, M., & Spiers, P. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.10.007 · Cited by 208
ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS
Daood, M. J., Tsai, C., Ahdab-Barmada, M., & Watchko, J. F. (2008) · Neuropediatrics · doi:10.1055/s-0028-1103272 · Cited by 208
Epilepsy and Inflammation in the Brain: Overview and Pathophysiology
Vezzani, A. (2014) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-14.s2.3 · Cited by 207
Hartz, A. M. S., Bauer, B., Fricker, G., & Miller, D. S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017954 · Cited by 203
Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System
Campos‐Bedolla, P., Walter, F. R., Veszelka, S., & Deli, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.018 · Cited by 202
Modulation of human BCRP (ABCG2) activity by anti-HIV drugs
Weiss, J., Rose, J., Storch, C. H., Ketabi‐Kiyanvash, N., Sauer, A., Haefeli, W. E., & Efferth, T. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl474 · Cited by 193
Bauer, B., Yang, X., Hartz, A. M. S., Olson, E. R., Zhao, R., Kalvass, J. C., Pollack, G. M., & Miller, D. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023796 · Cited by 192
P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study
Feldmann, M., Asselin, M., Liu, J. Y. W., Wang, S., McMahon, A. W., Anton‐Rodriguez, J., Walker, M. D., Symms, M. R., Brown, G. D., Hinz, R., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70109-1 · Cited by 190
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Krohn, M., Lange, C., Hofrichter, J., Scheffler, K., Stenzel, J., Steffen, J., Schumacher, T., Brüning, T., Plath, A.-S., Alfen, F., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57867 · Cited by 183
ABC transporters at the blood–brain barrier
Mahringer, A., & Fricker, G. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1168804 · Cited by 181
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
Bakos, É., & Homolya, L. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0160-8 · Cited by 180
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review
Dinda, B., Dinda, M., Kulsi, G., Chakraborty, A., & Dinda, S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.03.009 · Cited by 178
An, S., Groves, M., Gray, F., & Scaravilli, F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199911000-00005 · Cited by 177
Spudich, A., Kılıç, E., Xing, H., Kılıç, Ü., Rentsch, K., Wunderli‐Allenspach, H., Bassetti, C. L., & Hermann, D. M. (2006) · Nature Neuroscience · doi:10.1038/nn1676 · Cited by 177
Supportive and symptomatic management of amyotrophic lateral sclerosis
Hobson, E., & McDermott, C. J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.111 · Cited by 175
Ritter, C. A., Jedlitschky, G., zu Schwabedissen, H. E. M., Grube, M., Köck, K., & Kroemer, H. K. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200047984 · Cited by 174
Potential role of ABC transporters as a detoxification system at the blood?CSF barrier
DELANGE, E. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.009 · Cited by 170
Efflux transporters in blood-brain interfaces of the developing brain
Strazielle, N., & Ghersi‐Egea, J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00021 · Cited by 168
Qosa, H., Abuznait, A. H., Hill, R. A., & Kaddoumi, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120319 · Cited by 167
Wang, X., Campos, C. R., Peart, J. C., Smith, L. K., Boni, J. L., Cannon, R. E., & Miller, D. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2935-13.2014 · Cited by 164
Mechanisms of antiepileptic drug resistance
Sisodiya, S. M. (2003) · Current Opinion in Neurology · doi:10.1097/00019052-200304000-00013 · Cited by 164
Bart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
Bartels, A. L., Kortekaas, R., Bart, J., Willemsen, A. T. M., de Klerk, O. L., de Vries, J. J., van Oostrom, J. C. H., & Leenders, K. L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.002 · Cited by 163
Rapid Regulation of P-Glycoprotein at the Blood-Brain Barrier by Endothelin-1
Hartz, A. M. S., Bauer, B., Fricker, G., & Miller, D. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001503 · Cited by 161
Narang, V. S., Fraga, C. H., Kumar, N., Shen, J., Throm, S. L., Stewart, C. F., & Waters, C. M. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00491.2007 · Cited by 157
zu Schwabedissen, H. E. M., Jedlitschky, G., Gratz, M., Haenisch, S., Linnemann, K., Fusch, C., Cascorbi, I., & Kroemer, H. K. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.003335 · Cited by 154
Döring, B., & Petzinger, E. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882353 · Cited by 153
Blood-CNS Barrier Impairment in ALS patients versus an animal model
Garbuzova-Davis, S. N., & Sanberg, P. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00021 · Cited by 152
P-Glycoprotein Function at the Blood–Brain Barrier: Effects of Age and Gender
van Assema, D. M. E., Lubberink, M., Boellaard, R., Schuit, R. C., Windhorst, A. D., Scheltens, P., Lammertsma, A. A., & van Berckel, B. N. M. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0556-0 · Cited by 149
The role of astrocytes in amyloid β-protein toxicity and clearance
Thal, D. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.04.021 · Cited by 146
Cannon, R. E., Peart, J. C., Hawkins, B. T., Campos, C. R., & Miller, D. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203534109 · Cited by 146
Regulation of ABC Transporters Blood–Brain Barrier
Miller, D. S. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.10.002 · Cited by 146
Qosa, H., Abuasal, B. S., Romero, I. A., Weksler, B., Couraud, P.-O., Keller, J. N., & Kaddoumi, A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.023 · Cited by 146
Ronaldson, P. T., & Bendayan, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025973 · Cited by 145
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Wijesuriya, H. C., Bullock, J. Y., Faull, R. L. M., Hladky, S. B., & Barrand, M. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.034 · Cited by 141
Regulation of ABC transporters at the blood–brain barrier
Miller, D. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.64 · Cited by 139
Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier
Régina, A., Demeule, M., Laplante, A., Jodoin, J., Dagenais, C., Berthelet, F., Moghrabi, A., & Béliveau, R. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013104423154 · Cited by 136
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2
de Gooijer, M. C., de Vries, N. A., Buckle, T., Buil, L. C. M., Beijnen, J. H., Boogerd, W., & van Tellingen, O. (2018) · Neoplasia · doi:10.1016/j.neo.2018.05.001 · Cited by 136
Neutrophils and the blood–brain barrier dysfunction after trauma
Scholz, M., Cinatl, J. J., Schädel-Höpfner, M., & Windolf, J. (2006) · Medicinal Research Reviews · doi:10.1002/med.20064 · Cited by 134
Goralski, K. B., Hartmann, G., Piquette‐Miller, M., & Renton, K. W. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705227 · Cited by 130
Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP
Gameiro, M., Silva, R. V. D. S., Rocha‐Pereira, C., Carmo, H., Carvalho, F. D., Bastos, M. D. L., & Remião, F. (2017) · Molecules · doi:10.3390/molecules22040600 · Cited by 129
Self-citationChronic inflammation in multiple sclerosis - seeing what was always there
Matthews, P. M. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0240-y · Cited by 128
Candela, P., Gosselet, F., Saint-Pol, J., Sevin, E., Boucau, M.-C., Boulanger, E., Cecchelli, R., & Fenart, L. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100462 · Cited by 128
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
Wang, X., Sykes, D. B., & Miller, D. S. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.063685 · Cited by 127
Felix, R. A., & Barrand, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00660.x · Cited by 125
van Vliet, E. A., Redeker, S., Aronica, E., Edelbroek, P. M., & Gorter, J. A. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00250.x · Cited by 125
Nuclear Receptors: Overview and Classification
Novac, N., & Heinzel, T. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010042634541 · Cited by 124
Kemper, E. M., Verheij, M., Boogerd, W. J., Beijnen, J. H., & van Tellingen, O. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.01.024 · Cited by 123
ABCG2 reduces ROS‐mediated toxicity and inflammation: a potential role in Alzheimer’s disease
Shen, S., Callaghan, D., Juźwik, C. A., Xiong, H., Huang, P., & Zhang, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06887.x · Cited by 122
Function of β‐amyloid in cholesterol transport: a lead to neurotoxicity
Yao, Z., & Papadopoulos, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0285fje · Cited by 120
Couture, L., Nash, J. A., & Turgeon, J. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.2.7 · Cited by 120
ABCG2- and ABCG4-Mediated Efflux of Amyloid-β Peptide 1-40 at the Mouse Blood-Brain Barrier
Minh, T. N., Noël‐Hudson, M., Ribes, S., Besengez, C., Smirnova, M., Cisternino, S., Buyse, M., Calon, F., Chimini, G., Chacun, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112189 · Cited by 116
Aβ1–42 reduces P-glycoprotein in the blood–brain barrier through RAGE–NF-κB signaling
Park, R., Kook, S.-Y., Park, J.-C., & Mook‐Jung, I. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.258 · Cited by 116
Creutzfeldt-Jakob disease: recent developments
Mackenzie, G. M., & Will, R. G. (2017) · F1000Research · doi:10.12688/f1000research.12681.1 · Cited by 116
Randolph, S. A. (2016) · Workplace Health & Safety · doi:10.1177/2165079916665400 · Cited by 116
Over-expression of Pglycoprotein in malformations of cortical development
Sisodiya, S. M., Heffernan, J. M., & Squier, M. V. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00032 · Cited by 115
Research works printed but not linked: 3
- Goldenberg, 2012, Multiple sclerosis review, Pharmacy and Therapeutics, 37, 175
- Liu, 2018, Effects of the antiretroviral drug 2′-deoxy-2′-beta-fluoro-4′-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions, Pharmazie, 73, 503
- Schulz, 2015, Depression, Continuum (Minneap Minn), 21, 756, 10.1212/01.CON.0000466664.35650.b4 · DOI
Cited by
Sorted by citations
Zhou, X., Smith, Q. R., & Liu, X. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1695 · Cited by 229
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Correia, A. D. A., Monteiro, A. R., Silva, R., Moreira, J. N., Lobo, J. M. S., & Silva, A. C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114485 · Cited by 219
Self-citationHypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases
Merelli, A., Repetto, M. G., Lazarowski, A., & Auzmendi, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201074 · Cited by 188
Feng, J., Zheng, Y., Guo, M., Arés, I., Martínez, M., López-Torres, B., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.07.010 · Cited by 187
Metadata
- Authors
- Gil-Martins, E., Barbosa, D. J., Silva, V., Remião, F., & Silva, R.
- Affiliations
- Universidade do Porto (PT)
- Corresponding author
- Remião, Fernando
- Silva, Renata
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 213
- Pages
- 107554
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W3017050326
- Cited by
- 152
- References
- 379
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 18 · 2023: 33 · 2022: 33 · 2021: 22 · 2020: 7
- FWCI
- 2.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- ABC transporters, blood-brain barrier, P-glycoprotein, ABCG2, multidrug resistance protein, neurological disorders, epilepsy, multiple sclerosis, Alzheimer's disease, amyotrophic lateral sclerosis, drug resistance, signaling pathways, transporter regulation, drug bioavailability
- MeSH terms
- Animals, Blood-Brain Barrier, Brain, Central Nervous System Agents, Drug Resistance, Humans, Nervous System Diseases, ATP-Binding Cassette Transporters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
